¹MD, Medical College of Georgia, Augusta University, USA

²MD, Ascension Providence Hospital, USA

³DO, Ascension Providence Hospital, USA

*Corresponding author: Jordan Ciuro, MD, Medical College of Georgia, Augusta University, USA, Tel: 2489908850; Emails: [email protected]; [email protected].

Received Date: March 20, 2023

Published Date: April 06, 2023

Citation: Ciuro J, et al. (2023). The Role of Pneumocystis Pneumonia Prophylaxis in Hematologic Malignancies: A Case Report and Review of Literature. Mathews J Case Rep. 8(4):102.

Copyrights: Ciuro J, et al. © (2023).

ABSTRACT

Pneumocystis pneumonia (PCP) is a potentially life-threatening infection that occurs in immunocompromised individuals. Currently, there are no published and standard guidelines regarding the use of PCP prophylaxis in patients with aggressive hematologic malignancies. Here, we present a clinical case of a patient who was recently diagnosed with T-cell lymphoma and did not receive PCP prophylaxis leading to acute respiratory failure from PCP infection and a complicated ICU hospital course. Our case and review of the literature highlight the critical importance of further analysis of PCP prophylaxis to provide a consensus in treatment guidelines for physicians with the goal of decreasing mortality from a possible preventable infection in immunocompromised patients.

Keywords: Pneumocystis Pneumonia, Patients, Acute Respiratory Failure, T-cell Lymphoma, Pulmonary Involvement.